CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Sarah M. Larson, Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha, Thomas Schweppe, Beata Berent-Maoz, Stanley B. Gosliner, Amr Almaktari, Melanie Ayala Ceja, Martin S. Allen-Auerbach, Jonathan Said, Karla Nawaly, Monica Mead, Sven de Vos, Patricia A. Young, Caspian Oliai, Gary J. Schiller, John M. Timmerman, Antoni Ribas, Yvonne Y. Chen

Open source

DOI: 10.1158/2159-8290.cd-22-0964
Published: 2022-11-23
Container: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2159-8290.cd-22-0964,
  title = {CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma},
  author = {Sarah M. Larson and Christopher M. Walthers and Brenda Ji and Sanaz N. Ghafouri and Jacob Naparstek and Jacqueline Trent and Jia Ming Chen and Mobina Roshandell and Caitlin Harris and Mobina Khericha and Thomas Schweppe and Beata Berent-Maoz and Stanley B. Gosliner and Amr Almaktari and Melanie Ayala Ceja and Martin S. Allen-Auerbach and Jonathan Said and Karla Nawaly and Monica Mead and Sven de Vos and Patricia A. Young and Caspian Oliai and Gary J. Schiller and John M. Timmerman and Antoni Ribas and Yvonne Y. Chen},
  year = {2022},
  journal = {Cancer Discovery},
  doi = {10.1158/2159-8290.cd-22-0964},
  url = {https://doi.org/10.1158/2159-8290.cd-22-0964}
}

RIS

TY  - JOUR
TI  - CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
AU  - Sarah M. Larson
AU  - Christopher M. Walthers
AU  - Brenda Ji
AU  - Sanaz N. Ghafouri
AU  - Jacob Naparstek
AU  - Jacqueline Trent
AU  - Jia Ming Chen
AU  - Mobina Roshandell
AU  - Caitlin Harris
AU  - Mobina Khericha
AU  - Thomas Schweppe
AU  - Beata Berent-Maoz
AU  - Stanley B. Gosliner
AU  - Amr Almaktari
AU  - Melanie Ayala Ceja
AU  - Martin S. Allen-Auerbach
AU  - Jonathan Said
AU  - Karla Nawaly
AU  - Monica Mead
AU  - Sven de Vos
AU  - Patricia A. Young
AU  - Caspian Oliai
AU  - Gary J. Schiller
AU  - John M. Timmerman
AU  - Antoni Ribas
AU  - Yvonne Y. Chen
PY  - 2022
JO  - Cancer Discovery
DO  - 10.1158/2159-8290.cd-22-0964
UR  - https://doi.org/10.1158/2159-8290.cd-22-0964
ER  -

APA

Larson, S. M., Walthers, C. M., Ji, B., Ghafouri, S. N., Naparstek, J., Trent, J., Chen, J. M., Roshandell, M., Harris, C., Khericha, M., Schweppe, T., Berent-Maoz, B., Gosliner, S. B., Almaktari, A., Ceja, M. A., Allen-Auerbach, M. S., Said, J., Nawaly, K., Mead, M., Vos, S. D., Young, P. A., Oliai, C., Schiller, G. J., Timmerman, J. M., Ribas, A., & Chen, Y. Y. (2022). CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-22-0964

Source records

crossref · retrieved 2026-09-26T22:55:55.531Z